- Potential benefitMay create construction and manufacturing jobs building and operating domestic formula facilities.
- Potential benefitIncreases domestic infant formula supply, potentially reducing reliance on imports and shortages.
- TaxpayersDirects incentives toward smaller and mid‑sized manufacturers by limiting eligibility to taxpayers under $750 million.
Infant Formula Made in America Act of 2025
Referred to the House Committee on Ways and Means.
The bill creates two federal tax incentives to expand U.S. infant formula production: a 30% investment tax credit for qualified domestic manufacturing projects and a $2-per-pound production credit for eligible domestic formula producers. Both credits target smaller producers (global revenue under $750 million), include certification, caps, recapture provisions, portability/elective-payment options, and limits on total and per-project allocations.
Progressives emphasize public-health and domestic-resilience benefits
Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those credits into the Internal Revenue Code.
The bill creates two federal tax incentives to expand U.S. infant formula production: a 30% investment tax credit for qualified domestic manufacturing projects and a $2-per-pound production credit for eligible domestic formula producers.
Both credits target smaller producers (global revenue under $750 million), include certification, caps, recapture provisions, portability/elective-payment options, and limits on total and per-project allocations.
The investment credit has per-project ($150M) and aggregate ($750M) caps and a 10-year construction commencement window; the production credit is limited to 18 million pounds per taxpayer per year and a five-year eligibility window.
Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.
Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those credits into the Internal Revenue Code.
Progressives emphasize public-health and domestic-resilience benefits
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesReduces federal revenues via new tax credits, with fiscal cost depending on program uptake.
- ManufacturersTransferability could allow investors or third parties to capture credit value instead of manufacturers.
- Potential burdenMay distort market incentives, favoring formula production investment over other infant nutrition priorities.
Why the argument around this bill splits.
Progressives emphasize public-health and domestic-resilience benefits
Likely cautiously supportive.
The bill aims to rebuild domestic capacity and supply resilience while prioritizing smaller producers, which aligns with labor and public-health concerns, but it uses business tax incentives rather than direct public investment or strict labor/environmental conditions.
Generally favorable as a targeted, time-limited tool to shore up supply chains and domestic production.
Sees sensible guardrails (revenue cap, recapture, caps) but will want clearer cost estimates, administrative plans, and monitoring to prevent waste.
Mixed.
Supports domestic manufacturing and supply security but skeptical of targeted tax subsidies and federal intervention that pick specific industries.
May prefer broader tax relief or deregulation instead of new credits and federal certification programs.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.
- No official cost or CBO estimate provided
- Which agency/Secretary administers certification and criteria
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize public-health and domestic-resilience benefits
Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.
Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those cr…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.